Optimising procedure management for marketing authorisation of veterinary medicines in Eastern Africa

Timely and effective marketing authorisation of veterinary medicines requires a combination of rigorous scientific evaluation and efficient management of procedures.  In line with GALVmed’s role in implementing the AgResults Foot […]

Rapid landscaping analysis to understand the gender implications of the PREVENT project

In 2021, GALVmed and Ceva Santé Animale launched PREVENT (PRomoting and Enabling Vaccination Efficiently, Now and Tomorrow), a 4-year initiative that aims to improve the efficiency and sustainability of small-scale […]

GALVmed and Elanco launch a new initiative empowering small-scale producers in Sub-Saharan Africa

Edinburgh, UK (March 16, 2022) – The Global Alliance for Livestock Veterinary Medicines (GALVmed) has partnered with Elanco Animal Health to launch a new initiative to manage ticks and tick-borne […]

A letter from our CEO: 2022 is a year of re-engagement and re-activation

At the occasion of the first Newsletter of the year, please receive my heartfelt wishes for a distinctively healthy, happy and prosperous New Year. I sincerely hope that the epidemiological […]

Mkuza Chicks in Tanzania Partners with PREVENT to Vaccinate Day Old Chicks

Located in Pwani region to the east of Tanzania’s Dar es Salaam region, Mkuza farm is a family hatchery business which has been in operation for more than twenty years. […]

TribeCo receives six million poultry vaccine doses from Ceva

TribeCo, GALVmed’s animal distribution partner in Ghana, recently took possession of six million doses of various poultry vaccines from veterinary health company Ceva Santé Animale. The consignment, which was delivered […]

Our health systems won’t prevent pandemics, unless G20 invest in animal health

An open letter to G20 leaders from the Action for Animal Health coalition.   Even before the COVID-19 pandemic wreaked havoc on our lives, diseases from animals were causing 2.7 million human […]

Appointment of new Senior Director of Research & Development

  GALVmed is pleased to announce the appointment of Dr Johnson Ouma as the new Senior Director of Research & Development, effective October 11, 2021. Dr Ouma is a Kenyan […]

Letter from our CEO: Carolin Schumacher reflects on the challenges of 2020

2020 was a year marked by unprecedented disruptions as most of us dealt with the effects of COVID-19-associated health concerns, lockdown restrictions and economic disruption. While the Pandemic caused delays […]

Vaccination against Newcastle Disease increases productivity in chickens

An analysis of the impact of Newcastle Disease vaccination in Uganda has demonstrated substantial effect on chicken flock production. Whilst several studies have demonstrated the clear beneficial impact that vaccinating […]